Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Takeno (Yufu, Japan), K. Umeki (Yufu, Japan), K. Komiya (Yufu, Japan), Y. Usagawa (Yufu, Japan), M. Yamasue (Yufu, Japan), S. Nureki (Yufu, Japan), M. Ando (Yufu, Japan), K. Hiramatsu (Yufu, Japan), J. Kadota (Yufu, Japan). Lymphocytes in bronchoalveolar lavage fluid might be useful for predicting the prognosis, even in the stable phase of nonspecific interstitial pneumonia. 2945

Member's Comments

No comment yet.

Related content which might interest you: Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Subpopulations of cells from bronchoalveolar lavage can predict prognosis in sarcoidosis Source: Eur Respir J, 55 (1) 1901450; 10.1183/13993003.01450-2019 Year: 2020 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP) Source: Eur Respir J 2004; 24: Suppl. 48, 46s Year: 2004 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Changes of pneumonia patients bronchoalveolar lavage fluid cellular components Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002 Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001 Metabolite markers identify pneumonia better in serum than sputum or broncho-alveolar lavage fluid Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 High level of leukotriene B4 in bronchoalveolar lavage fluid is associated with poor prognosis in patients with interstitial pneumonia Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Comparison between induced sputum and bronchoalveolar lavage fluid for diagnosis of pulmonary tuberculosis Source: Annual Congress 2010 - Scientific advances in tuberculosis Year: 2010 Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 The importance of cytological analysis of bronchoalveolar lavage in tuberculous lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 662s Year: 2007 The relationship between the course of sarcoidosis and changes of markers of the disease activity in a bronchoalveolar lavage fluid Source: Eur Respir J 2002; 20: Suppl. 38, 469s Year: 2002 The role of bronchoalveolar lavage immunologic parameters in pulmonary sarcoidosis prognosis Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease Source: Eur Respir Rev 2010 19: 237-241 Year: 2010 Activation markers of lymphocytes in bronchoalveolar lavage fluid of different sarcoidosis stages Source: Eur Respir J 2003; 22: Suppl. 45, 265s Year: 2003 The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013